Two new studies shed light on the costs associated with newer weight loss drugs and their use before bariatric surgery. Long term, the cost effectiveness of bariatric surgery is greater than that of ...

Please provide your email address to receive an email when new articles are posted on . For patients with obesity, bariatric surgery was more cost-effective than GLP-1 receptor agonists. The biggest ...

Amid rising concern about the potential long-term costs of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity, some insurers are making access to bariatric surgery easier. While the ...

Research led by a Northwestern Medicine team found that, despite higher upfront costs, bariatric surgeries offer two more quality years of life compared to GLP-1 therapies. The long-term ...

Please provide your email address to receive an email when new articles are posted on . In recent years, use of obesity drugs has increased, while bariatric surgery has decreased. In a new analysis, ...

Bariatric surgery is more cost-effective and offers better long-term outcomes than GLP-1 RAs for obesity and metabolic comorbidities. GLP-1 RAs face challenges like high costs, limited insurance ...